Bayer and Adidas stocks react to legal battles and World Cup boost

The Bayer share edged up modestly to about €36.42 in early trading, marking a slight stabilization after months of volatility. Investors remain cautious as the company continues to grapple with extensive U.S. glyphosate litigation stemming from the 2018 Monsanto acquisition, despite ongoing operational improvements and a modest analyst price target of €40.50.

Adidas’ stock rose to €175.40, buoyed by strong first‑quarter earnings and the prospect of the 2026 FIFA World Cup, which the German sportswear maker will help outfit. The firm expects the tournament to generate over €1 billion in additional revenue and has set a consensus analyst price target of €211. Both companies are key components of Germany’s DAX index.